Northwest Biotherapeutics Statistics
Total Valuation
NWBO has a market cap or net worth of $469.22 million. The enterprise value is $515.82 million.
| Market Cap | 469.22M |
| Enterprise Value | 515.82M |
Important Dates
The last earnings date was Tuesday, February 28, 2023.
| Earnings Date | Feb 28, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
NWBO has 1.21 billion shares outstanding. The number of shares has increased by 10.54% in one year.
| Shares Outstanding | 1.21B |
| Shares Change (YoY) | +10.54% |
| Shares Change (QoQ) | +3.22% |
| Owned by Insiders (%) | 9.16% |
| Owned by Institutions (%) | 0.05% |
| Float | 1.10B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 351.21 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 386.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.08
| Current Ratio | 0.08 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -17.17 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -247.08% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $53,440 |
| Profits Per Employee | -$2.83M |
| Employee Count | 25 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NWBO has paid $890,000 in taxes.
| Income Tax | 890,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.78% in the last 52 weeks. The beta is -0.58, so NWBO's price volatility has been lower than the market average.
| Beta (5Y) | -0.58 |
| 52-Week Price Change | -30.78% |
| 50-Day Moving Average | 0.44 |
| 200-Day Moving Average | 0.59 |
| Relative Strength Index (RSI) | 35.13 |
| Average Volume (20 Days) | 1,809,003 |
Short Selling Information
The latest short interest is 14.14 million, so 1.17% of the outstanding shares have been sold short.
| Short Interest | 14.14M |
| Short Previous Month | 13.83M |
| Short % of Shares Out | 1.17% |
| Short % of Float | 1.29% |
| Short Ratio (days to cover) | 13.54 |
Income Statement
In the last 12 months, NWBO had revenue of $1.34 million and -$70.78 million in losses. Loss per share was -$0.06.
| Revenue | 1.34M |
| Gross Profit | -500,000 |
| Operating Income | -58.29M |
| Pretax Income | -70.78M |
| Net Income | -70.78M |
| EBITDA | -56.84M |
| EBIT | -58.68M |
| Loss Per Share | -$0.06 |
Balance Sheet
The company has $2.48 million in cash and $49.08 million in debt, giving a net cash position of -$46.60 million or -$0.04 per share.
| Cash & Cash Equivalents | 2.48M |
| Total Debt | 49.08M |
| Net Cash | -46.60M |
| Net Cash Per Share | -$0.04 |
| Equity (Book Value) | -53.39M |
| Book Value Per Share | -0.04 |
| Working Capital | -57.49M |
Cash Flow
In the last 12 months, operating cash flow was -$54.80 million and capital expenditures -$2.34 million, giving a free cash flow of -$57.15 million.
| Operating Cash Flow | -54.80M |
| Capital Expenditures | -2.34M |
| Free Cash Flow | -57.15M |
| FCF Per Share | -$0.05 |
Margins
Gross margin is -37.43%, with operating and profit margins of -4,362.87% and -5,297.75%.
| Gross Margin | -37.43% |
| Operating Margin | -4,362.87% |
| Pretax Margin | -5,297.75% |
| Profit Margin | -5,297.75% |
| EBITDA Margin | -4,254.64% |
| EBIT Margin | -4,392.07% |
| FCF Margin | -4,277.47% |
Dividends & Yields
NWBO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.54% |
| Shareholder Yield | -10.54% |
| Earnings Yield | -15.08% |
| FCF Yield | -12.18% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on September 26, 2012. It was a reverse split with a ratio of 1:16.
| Last Split Date | Sep 26, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:16 |
Scores
NWBO has an Altman Z-Score of -73.04 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -73.04 |
| Piotroski F-Score | 3 |